AstraZeneca and Bristol Myers Squibb do not have any ongoing discussions about a potential deal,
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says
AstraZeneca and Bristol Myers Squibb merger talks denied
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
Pharma giants AstraZeneca and Bristol-Myers in reported merger talks
AstraZeneca, Bristol Myers are in talks about merger — report
AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources
AstraZeneca-Bristol Myers megamerger talk leaves Wall Street wanting more answers
AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)
Pharmalittle: We're reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more
AstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no…
Earlier reports said the two drugmakers held talks about a possible deal that would create a pharmaceutical behemoth. Read more…
A source close to the matter told Reuters there is "no deal" and there "never was a deal to be done" between the two drugmakers
It’s been years since Big Pharma last witnessed a megamerger. In the late 2010s, Takeda bought Shire, AbbVie acquired Allergan,…
Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma…
An agreement would invite government scrutiny on both sides of the pond.
